# Illumina MiSeq i100 System or equal

Canonical: https://abierto.us/opportunities/noioc2026132529

- Solicitation number: NOI_OC-2026-132529
- Notice type: Special notice
- Status: Closed. Deadline was March 26, 2026 at 2:30 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 334516 Analytical Laboratory Instrument Manufacturing
- Product or service code: 6640 Laboratory Equipment and Supplies
- First posted: March 20, 2026
- Last posted: March 20, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/6e4695e321fa4175bd2e225d9d9fa972/view

## Description

NOTICE OF INTENT TO SOLE SOURCE Description This notice is issued for informational and market research purposes only and does not constitute a solicitation. The FDA intends to award a sole source Firm-Fixed-Price purchase order for one (1) Whole Genome Sequencing instrument. The Government is considering the Illumina MiSeq i100 System or equal product that meets all salient characteristics identified in the Statement of Work (SOW).

Offerors proposing equal products shall demonstrate how the proposed product meets each of the salient characteristics The instrument shall include a minimum one (1) year manufacturer’s warranty covering parts and labor. Response Instructions Interested parties shall submit capability statements demonstrating ability to meet requirements. Offerors proposing an equivalent must clearly demonstrate how requirements are met. Response Deadline March 26, 2026, at 2:30 PM ET Submission Contracting Officer:

**Iris Johnson Email:** Iris.Johnson1@fda.hhs.gov

## Publications

- March 20, 2026: Special notice, due March 26, 2026 at 2:30 PM EDT. Notice 6e4695e321fa4175bd2e225d9d9fa972. https://sam.gov/workspace/contract/opp/6e4695e321fa4175bd2e225d9d9fa972/view

## Points of contact

- Iris Johnson, Iris.Johnson1@fda.hhs.gov, 3017963353

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/noioc2026132529.